(Ottawa, Ontario – June 21, 2017) – The Canadian Centre for Ethics in Sport (CCES) announced today that Youssef Youssef, a judo athlete, received a sanction of four years for a second anti-doping rule violation. The athlete’s urine sample, collected during out-of-competition doping control on February 8, 2017, revealed the presence of tamoxifen.
Tamoxifen is classified as a “specified substance” on the World Anti-Doping Agency Prohibited List. The standard starting sanction for a tamoxifen violation is a two-year period of ineligibility. However, since Mr. Youssef is currently serving a period of ineligibility related to a Presence violation committed in 2016, the tamoxifen violation is treated as a second anti-doping rule violation and the resulting period of ineligibility is four years.
In accordance with the Canadian Anti-Doping Program (CADP), if an athlete fails to dispute the anti-doping rule violation within the timelines specified in the CADP, the violation and the sanction are confirmed by way of a Deemed Waiver. Since Mr. Youssef did not engage in the results process, the violation was confirmed and a sanction was imposed starting April 20, 2017. The athlete, who resides in Toronto, Ontario, remains ineligible to participate in any capacity with any sport signatory to the CADP, including training with teammates, until April 19, 2021.
In compliance with rule 7.10 of the CADP, a copy of the CCES’ file summary can be found at www.cces.ca/sanctionreg.
The CCES is an independent, national, not-for profit organization with a responsibility to administer the CADP. Under the CADP rules, the CCES announces publicly every anti-doping rule violation. We recognize that true sport can make a great difference for individuals, communities and our country. We are committed to working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.
For further information, please contact:
613 521-3340 x3314